Pelabresib recently met its primary endpoint of spleen volume reduction and demonstrated favorable trends in symptom improvement
The workshop was conducted as a part of the NITI–State workshop series
Three block copolymers added to RESOMER portfolio of bioabsorbable polymers
The introduction of 'Definisse Core Filler' is a testament to the company's premium scientific-based innovation
The state of the healthcare services will improve substantially with the involvement and participation of ULBs
The Leaders of G20 met in New Delhi and committed to strengthening global health and implementing one health approach
There is a pressing need for continuous improvement and innovation in food safety systems to keep pace with emerging food trends and habits
These initiatives aim to improve access to healthcare for rare disease patients
Acquisition of XinThera provides Gilead with precision small molecules focused on PARP1 and MK2 Inhibitors
Cipla has recently signed an agreement to make and market the diabetes therapy Galvus and its combination brands in India from 01 January 2026.
Subscribe To Our Newsletter & Stay Updated
